Humacyte
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $467 | $753 | $301 | $517 |
Gross Profit | -12,268 | 493 | -1,772 | -1,462 |
EBITDA | -97,777 | -13,033 | -33,253 | 43,971 |
EBIT | -99,565 | -14,898 | -35,113 | 42,139 |
Net Income | -24,804 | -17,510 | -37,658 | 39,139 |
Net Change In Cash | 467 | 753 | 301 | 517 |
Free Cash Flow | -26,162 | -23,953 | -26,981 | -28,829 |
Cash | 50,497 | 19,488 | 38,032 | 62,847 |
Basic Shares | 158,160 | 158,313 | 155,437 | 131,759 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $2,038 | $0 | $0 | $1,565 |
Gross Profit | -15,009 | -7,190 | -76,550 | -6,690 |
EBITDA | -100,092 | -132,234 | -96,458 | -76,368 |
EBIT | -107,437 | -139,424 | -104,177 | -84,578 |
Net Income | -40,833 | -148,701 | -110,776 | -11,965 |
Net Change In Cash | 2,038 | 0 | 0 | 1,565 |
Cost of Revenue | -67,730 | |||
Free Cash Flow | -105,926 | -99,694 | -75,585 | -72,177 |
Cash | 50,497 | 44,937 | 80,448 | 149,772 |
Basic Shares | 158,160 | 118,479 | 103,420 | 103,051 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.18 |
2025-09-30 | -$0.11 |
2025-06-30 | -$0.24 |